Showing results (101-110 of 255) with videos related to
Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2012
Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare StudyJonathan W Friedberg, Michelle Byrtek, Brian K Link, et al.British Journal of Haematology|May 11, 2021
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)Mathias J Rummel, Ann Janssens, David MacDonald, et al.Clinical Immunology (Orlando, Fla.)|September 30, 2006
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogenyJennifer H Anolik, Jonathan W Friedberg, Bo Zheng, et al.Leukemia & Lymphoma|April 6, 2004
FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparisonJonathan W Friedberg, Alan Fischman, Donna Neuberg, et al.Clinical Lymphoma, Myeloma & Leukemia|November 10, 2018
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center ExperienceAnnaLynn M Williams, Andrea M Baran, Carla Casulo, et al.Archives of Pathology & Laboratory Medicine|September 11, 2007
Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutationJanet Graham, Maria Debiec-Rychter, Christopher L Corless, et al.Cancer|March 27, 2014
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United StatesLoretta J Nastoupil, Rajni Sinha, Michelle Byrtek, et al.American Journal of Hematology|May 11, 2012
Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopeniaRobin Reid, John M Bennett, Michael Becker, et al.Blood|November 10, 2023
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapyJonathan W Friedberg, Rodolfo Bordoni, Dipti Patel-Donnelly, et al.Cancer|March 22, 2012
Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare StudyChadi Nabhan, Michelle Byrtek, Michael D Taylor, et al.Pageof 26